Composition comprising prostacyclin andor analogues thereof for treatment of acute critically ill patients
US11714094B2 · kind B2 · utility
0Cited by
0References
21Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 3, 2020 |
| Grant date | Aug 1, 2023 |
| Priority date | — |
| Expiry date | Mar 16, 2042 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2300/00
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
Use of prostacyclin or an analogue thereof for treatment of a new medical indication in acute critically ill patients, in particular acute critically ill patients with systemic endothelial damage, a biomarker for identifying individuals that have a new medical indication, and a method for identifying a new medical indication.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.